Cargando…
AKR1B10 expression predicts response of gastric cancer to neoadjuvant chemotherapy
Effective methods for predicting tumor response to preoperative chemotherapy are required. Aldo-ketoreductase family 1 member B10 (AKR1B10) is predominantly expressed in the gastrointestinal tract and serves an important function in cancer development and progression. The present study investigated...
Autores principales: | Ahmed, Syed Minhaj Uddin, Jiang, Zi Nong, Zheng, Zhao Hong, Li, Yulong, Wang, Xiu Jun, Tang, Xiuwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313001/ https://www.ncbi.nlm.nih.gov/pubmed/30655829 http://dx.doi.org/10.3892/ol.2018.9705 |
Ejemplares similares
-
Quinone oxidoreductase 1 is overexpressed in gastric cancer and associated with outcome of adjuvant chemotherapy and survival
por: Jiang, Zhi-Nong, et al.
Publicado: (2021) -
Expression of the Aldo-Ketoreductases AKR1B1 and AKR1B10 in Human Cancers
por: Laffin, Brian, et al.
Publicado: (2012) -
AKR1B1 and AKR1B10 as Prognostic Biomarkers of Endometrioid Endometrial Carcinomas
por: Hojnik, Marko, et al.
Publicado: (2021) -
AKR1B10 in gastrointestinal diseases
por: Shen, Yi, et al.
Publicado: (2015) -
The Role of AKR1B10 in Physiology and Pathophysiology
por: Endo, Satoshi, et al.
Publicado: (2021)